The New England Journal of Medicine
e-mail icon  FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |    Advanced Search
Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe
 
Book Review
PreviousPrevious
Volume 351:2665 December 16, 2004 Number 25
NextNext

Alzheimer Disease: Neuropsychology and Pharmacology

Since this article has no abstract, we have provided an extract of the first 100 words of the full text and any section headings.

 Sign up for free e-toc
 

This Article
-Full Text
- PDF
-PDA Full Text
-Purchase this article

Tools and Services
-Add to Personal Archive
-Add to Citation Manager
-Notify a Friend
-E-mail When Cited
-E-mail When Letters Appear

More Information
Edited by Gérard Emilien, Cécile Durlach, Kenneth L. Minaker, Bengt Winblad, Serge Gauthier, and Jean-Marie Maloteaux. 288 pp. Basel, Switzerland, Birkhäuser Verlag, 2004. $129. ISBN 3-7643-2426-0.

Less than 20 years ago, Alzheimer's disease was described in epidemiologic studies as "the silent epidemic." Some 10 years later, the first risk factors and genetic mutations were reported, and today the epidemic is no longer silent. Despite its subtitle of Neuropsychology and Pharmacology, this book has a broad scope, with excellent chapters on the causes of Alzheimer's disease and dementia. Its 15 chapters are organized into three sections, which deal with the biologic correlates of Alzheimer's disease, neuropsychology, and treatment. The section on biologic correlates reviews the causes, pharmacology, and molecular genetics of Alzheimer's disease, along with the various . . . [Full Text of this Article]




HOME  |  SUBSCRIBE  |  SEARCH  |  CURRENT ISSUE  |  PAST ISSUES  |  COLLECTIONS  |  PRIVACY  |  HELP  |  beta.nejm.org

Comments and questions? Please contact us.

The New England Journal of Medicine is owned, published, and copyrighted © 2008 Massachusetts Medical Society. All rights reserved.